Theses
ldri | Bruxelles Woluwe
THESES IN PROGRESS
Auquière Marie
Encapsulation of lipids and microARNs in extracellular vesicles for the treatment of multiple sclerosis
Directors : Anne des Rieux (ADDB/LDRI) and Giulio Muccioli 5BPBL/LDRI)
Cheng Chen
Metal-organic framework for oral antibody delivery for inflammatory bowel disease and colorectal cancer treatment
Director : Ana Beloqui Garcia (ADDB/LDRI)
Demain Chloé
Director: Anne des Rieux (ADDB/LDRI)
Detroz Fanny
Development of nanomedicines to tackle cystic fibrosis lung disease
Directors: Rita Vanbever (ADDB/LDRI) and Mireille Dumoulin (ULiège)
Guilbaud Léo
Exploiting the cGAS-STING pathway as therapeutic target in inflammatory bowel disease treatment
Director: Ana Beloqui (ADDB/LDRI); Co-director: Alessio Malfanti (ADDB/LDRI)
Hendrickx Pauline
Programmable Biomaterials Laboratory/EPFL - Exploring the use of DNA nanotechnology for the cytoplasmic delivery of therapeutic miRNA for spinal cord injury repair
Director : Anne des Rieux (ADDB/LDRI)
Hoflack Laurie
Development and pharmacological assessment of a dual nanocarrier containing pro-resolutive drugs in models of rheumatoid arthritis
Directors : Mireille Al Houayek (ADDB/BPBL) and Ana Beloqui Garcia (ADDB/LDRI)
Kasereka Lwalemene Guélor
Director: Ana Beloqui (ADDB/LDRI)
Lemaire Lorine
Design of an anti-elastase nanomedicine to prevent the evolution of emphysema in chronic obstructive pulmonary disease
Director: Rita Vanbever (ADDB/LDRI)
Ma Dan
Adipose tissue-targeted nanoparticle-based strategy for oral peptide delivery
Director : Ana Beloqui (ADDB/LDRI)
Marotti Valentina
Gene silencing of TNFα in inflammatory bowel disease treatment through a dual-shielding strategy via bioadhesive beads”.
Director: Ana Beloqui (ADDB/LDRI); Co-Director: Alessio Malfanti (ADDB/LDRI)
Muanga Kalunda Claude
Director: Ana Beloqui (ADDB/LDRI)
Parrens Paul
Engineering bacterocin-based nanomedicines for the eradication of Staphylococcus aureus intracellular reservoirs in the context of skin chronic infections
Director: Rita Vanbever (ADDB/LDRI); Co-director: Françoise Van Bambeke (TFAR FACM/LDRI)
Van den Bossche William
Gas-promoted microbubbles-based drug delivery systems for the delivery of biologics in inflammatory bowel disease treatment
Director: Ana Beloqui (ADDB/LDRI)
van Nedervelde Louise
cGAS STING silencing using targeted nanomedicines to alleviate neuroinflammation in the scope of spinal cord injury and promote functional recovery
Directors : Anne des Rieux (ADDB/LDRI) and Giulio Muccioli (BPBL/LDRI)